Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
索拉非尼可抑制细胞内信号通路，并诱导甲状腺癌细胞的细胞周期停滞和细胞死亡，无论其组织学来源或 BRAF 突变状态如何
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-015-1186-0
Martina Broecker-Preuss, Stefan Müller, Martin Britten, Karl Worm, Kurt Werner Schmid, Klaus Mann, Dagmar Fuhrer
